Morgan Stanley Does Large IP Securitization Deal
Could this be a resurgence of IP securitisation? Financial Times has reported a large IP securitisation deal worth $250M executed by Morgan Stanley with Vertex Pharmaceuticals. Investors’ return will be based on milestone royalty payments received from sales of a drug that hasn’t even been approved yet. Before the recession, securitizing intangibles was becoming somewhat popular. Many are aware of the Duncan Donuts deal that hit headlines everywhere. Still, these deals, along with most
Go here to read the rest:
Morgan Stanley Does Large IP Securitization Deal
Intellectual Property Watch » Blog Archive » WIPO Looks At Mandate …
Intellectual Property Watch provides independent news, features and analysis on international IP policymaking such as trade, health, digital rights, biodiversity and access to knowledge.
Read more from the original source:
Intellectual Property Watch » Blog Archive » WIPO Looks At Mandate …